NASDAQ: AVAHAveanna Healthcare Holdings Inc Stock
$2.62+0.05 (+1.95%)
Updated Dec 8, 2023
AVAH Price
$2.62
Fair Value Price
$2.80
Market Cap
$499.72M
52 Week Low
$0.67
52 Week High
$2.96
P/E
-1.42x
P/B
-4.73x
P/S
0.12x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.87B
Earnings
-$346.57M
Gross Margin
30.8%
Operating Margin
-10.66%
Profit Margin
-18.6%
Debt to Equity
-16.63
Operating Cash Flow
-$15M
Beta
1.12
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
AVAH Overview
Aveanna Healthcare Holdings Inc. provides private duty nursing, adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the U.S. Its care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company was incorporated in 2016 and is headquartered in Atlanta, GA.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AVAH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AVAH ($2.62) is undervalued by 6.5% relative to our estimate of its Fair Value price of $2.80 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
AVAH ($2.62) is not significantly undervalued (6.5%) relative to our estimate of its Fair Value price of $2.80 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
AVAH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AVAH due diligence checks available for Premium users.
Be the first to know about important AVAH news, forecast changes, insider trades & much more!
AVAH News
Valuation
AVAH fair value
Fair Value of AVAH stock based on Discounted Cash Flow (DCF)
Price
$2.62
Fair Value
$2.80
Undervalued by
6.50%
AVAH ($2.62) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AVAH ($2.62) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AVAH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
AVAH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.42x
Industry
12.34x
Market
31.32x
AVAH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-4.73x
Industry
4.23x
AVAH's financial health
Profit margin
Revenue
$478.0M
Net Income
-$102.4M
Profit Margin
-21.4%
AVAH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AVAH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.7B
Liabilities
$1.8B
Debt to equity
-16.63
AVAH's short-term liabilities ($364.30M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AVAH's long-term liabilities ($1.39B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AVAH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AVAH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$28.7M
Investing
-$1.1M
Financing
-$7.3M
AVAH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
AVAH vs Medical Care Facility Stocks
Aveanna Healthcare Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.